Community-associated methicillin-resistant Staphylococcus aureus skin infections in a religious community

Epidemiology and Infection

Volumn 135, Issue 3, 2007, Pages 492-501

  Coronado, F ^a,c   Nicholas, J A ^c   Wallace, B J ^c   Kohlerschmidt, D J ^d   Musser, K ^d   Schoonmaker Bopp, D J ^d   Zimmerman, S M ^e   Boller, A R ^e   Jernigan, D B ^b   Kacica, M A ^c  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^c NEW YORK STATE DEPARTMENT OF HEALTH   (United States)

^d WADSWORTH CENTER   (United States)

^e Esopus Medical   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIINFECTIVE AGENT; CEPHALOSPORIN; CHLORHEXIDINE; CHLORINE; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; DICLOXACILLIN; DISINFECTANT AGENT; ERYTHROMYCIN; GATIFLOXACIN; LEVOFLOXACIN; MACROLIDE; METICILLIN; OXACILLIN; PENICILLIN G; PSEUDOMONIC ACID; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; VANCOMYCIN;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL TRANSMISSION; BACTERIUM ISOLATE; CHILD; CLINICAL ARTICLE; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; ENVIRONMENTAL SANITATION; EPIDEMIC; FEMALE; HUMAN; INFECTION CONTROL; INFECTION RISK; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MULTIVARIATE ANALYSIS; NOSE SMEAR; PERSONAL HYGIENE; PULSED FIELD GEL ELECTROPHORESIS; RELIGION; RETROSPECTIVE STUDY; RISK FACTOR; SAUNA; SKIN INFECTION; SOFT TISSUE INFECTION; STAPHYLOCOCCUS INFECTION; WOUND CARE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; COMMUNITY-ACQUIRED INFECTIONS; DISEASE OUTBREAKS; FEMALE; HUMANS; HYGIENE; INFANT; MALE; METHICILLIN RESISTANCE; MIDDLE AGED; NASAL MUCOSA; RELIGION; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCAL SKIN INFECTIONS;

EID: 33947413434     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268806006960     Document Type: Article

References (38)

1. Vandenesch F, et al. Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerging Infectious Diseases 2003; 9: 978-984.
2. Chambers HF. The changing epidemiology of Staphylococcus aureus? Emerging Infectious Diseases 2001; 7: 178-181.
3. Centers for Disease Control and Prevention. Methicillin-resistant Staphylococcus aureus infections in correctional facilities - Georgia, California and Texas, 2001-2003. Morbidity and Mortality Weekly Report 2003; 52: 992-996.
4. Borer A, et al. Community-acquired methicillin-resistant Staphylococcus aureus in institutionalized adults with developmental disabilities. Emerging Infectious Diseases 2002; 8: 966-970.
5. Baggett HC, et al. An outbreak of community-onset methicillin-resistant Staphylococcus aureus skin infections in southwestern Alaska. Infection Control & Hospital Epidemiology 2003; 24: 397-402.
6. Centers for Disease Control and Prevention. Community-associated methicillin-resistant Staphylococcus aureus infections in Pacific Islanders - Hawaii, 2001-2003. Morbidity and Mortality Weekly Report 2004; 53: 767-770.
7. Zinderman CE, et al. Community-acquired methicillin-resistant Staphylococcus aureus among military recruits. Emerging Infectious Diseases 2004; 10: 941-944.
8. Centers for Disease Control and Prevention. Methicillin-resistant Staphylococcus aureus infections among competitive sports participant - Colorado, Indiana, Pennsylvania, and Los Angeles County, 2000-2003. Morbidity and Mortality Weekly Report 2003; 52: 793-795.
9. Jones TF, et al. An outbreak of community-acquired illness caused by methicillin-resistant Staphylococcus aureus. Emerging Infectious Diseases 2002; 8: 82-84.
10. Moreno F, et al. Methicillin-resistant Staphylococcus aureus as a community organism. Clinical Infectious Diseases 1995; 21: 1308-1312.
11. Herold BC, et al. Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. Journal of the American Medical Association 1998; 279: 593-598.
12. Kazakova SA, et al. A clone of methicillin-resistant Staphylococcus aureus among professional football players. New England Journal of Medicine 2005; 352: 468-475.
13. Baba T, et al. Genome and virulence determinants of high virulence community-acquired MRSA. Lancet 2002; 359: 1819-1827.
14. Gillet Y, et al. Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet 2002; 359: 753-759.
15. Saiman L, et al. Hospital transmission of community-acquired methicillin-resistant Staphylococcus aureus among postpartum women. Clinical Infectious Diseases 2003; 37: 1313-1319.
16. Carleton HA, et al. Community-adapted methicillin-resistant Staphylococcus aureus (MRSA): Population dynamics of an expanding community reservoir of MRSA. Journal of Infectious Diseases 2004; 190: 1730-1738.
17. Baggett HC, et al. Community-onset methicillin-resistant Staphylococcus aureus associated with antibiotic use and the cytotoxin Panton-Valentine leukocidin during a furunculosis outbreak in rural Alaska. Journal of Infectious Diseases 2004; 189: 1565-1573.
18. Sanderson WT, et al. Surface sampling methods for Bacillus anthracis spore contamination. Emerging Infectious Diseases 2002; 8: 1145-1151.
19. Tenover F, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: Criteria for bacterial strain typing. Journal of Clinical Microbiology 1995; 33: 2233-2239.
20. Centers for Disease Control and Prevention. PFGE plug procedure: Short form, Staphylococcus species. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, 2000.
21. Laupland KB, Conly JM. Treatment of Staphylococcus aureus colonization and prophylaxis for infection with topical intranasal mupirocin: An evidence-based review. Clinical Infectious Diseases 2003; 37: 933-938.
22. McDougal LK, et al. Pulse-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: Establishing a national database. Journal of Clinical Microbiology 2003; 41: 5113-5120.
23. Graffunder EM, Venezia RA. Risk factors associated with nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection including previous use of antimicrobials. Journal of Antimicrobial Chemotherapy 2002; 49: 999-1005.
24. Hidron AI, et al. Risk factors for colonization with methicillin-resistant Staphylococcus aureus (MRSA) in patients admitted to an urban hospital: Emergence of community-associated MRSA nasal carriage. Clinical Infectious Diseases 2005; 41: 159-166.
25. Ellis ME, et al. Natural history of community-acquired methicillin-resistant Staphylococcus aureus colonization and infection in soldiers. Clinical Infectious Diseases 2004; 39: 971-979.
26. Dancer SJ. How antibiotics can make us sick: The less obvious adverse effects of antimicrobial chemotherapy. Lancet Infectious Diseases 2004; 4: 611-619.
27. Bisognano C, et al. Increased expression of fibronectin-binding proteins by fluoroquinolone-resistant Staphylococcus aureus exposed to subinhibitory levels of ciprofloxin. Antimicrobial Agents Chemotherapy 1997; 41: 906-913.
28. Ohlsen K, et al. Effects of subinhibitory concentrations of antibiotics on alpha-toxin (hla) gene expression of methicillin-sensitive and methicillin-resistant Staphylococcus aureus isolates. Antimicrobial Agents Chemotherapy 1998; 42: 2817-2823.
29. Miller YW, et al. Sequential antibiotic therapy for acne promotes the carriage of resistant staphylococci on the skin of contacts. Journal Antimicrobial Chemotherapy 1996; 38: 829-837.
30. Naimi TA, et al. Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection. Journal American Medical Association 2003; 290: 2976-2984.
31. Begier EM, et al. A high-morbidity outbreak of methicillin-resistant Staphylococcus aureus among players on a college football team, facilitated by cosmetic body shaving and turf burns. Clinical Infectious Diseases 2004; 39: 1446-1453.
32. Nguyen DM, Mascola L, Bancroft E. Recurring methicillin-resistant Staphylococcus aureus infections in a football team. Emerging Infectious Diseases 2005; 11: 526-532.
33. Devine J, Cooke RPD, Wright EP. Is methicillin-resistant Staphylococcus aureus (MRSA) contamination of ward-based computer terminals a surrogate marker for nosocomial MRSA transmission and handwashing compliance? Journal of Hospital Infection 2001; 48: 72-75.
34. Bures S, et al. Computer keyboards and faucet handles as reservoirs of nosocomial pathogens in the intensive care unit. American Journal of Infection Control 2000; 28: 465-471.
35. Layton MC, et al. An outbreak of mupirocin-resistant Staphylococcus aureus on a dermatology ward associated with an environmental reservoir. Infection Control and Hospital Epidemiology 1993; 14: 369-375.
36. Blythe D, et al. Environmental contamination due to methicillin-resistant Staphylococcus aureus (MRSA). Journal of Hospital Infection 1998; 38: 67-69.
37. Lina G, et al. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clinical Infectious Diseases 1999; 29: 1128-1132.
38. Fridkin SK, et al. Methicillin-resistant Staphylococcus aureus disease in three communities. New England Journal of Medicine 2005; 352: 1436-1444.